Document ID: FDA-2010-N-0001-0037
Agency: fda
Document Type: Notice
Title: 2010 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments
Posted Date: 2010-04-02T04:00Z

[Federal Register: April 2, 2010 (Volume 75, Number 63)]
[Notices]               
[Page 16817]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02ap10-87]                         

[[Page 16817]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2010-N-0001]

 
2010 Scientific Meeting of the National Antimicrobial Resistance 
Monitoring System; Public Meeting; Request for Comments

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice of public meeting; request for comments.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
meeting entitled ``2010 Scientific Meeting of the National 
Antimicrobial Resistance Monitoring System.'' The topic to be discussed 
is the results from the National Antimicrobial Resistance Monitoring 
System (NARMS) and related antimicrobial resistance monitoring and 
research, including activities in other national programs.
    Date and Time: The public meeting will be held on July 15 and 16, 
2010, from 8 a.m. to 5 p.m.
    Location: The public meeting will be held at Hyatt Regency-Atlanta 
hotel, 265 Peachtree St. NE, Atlanta, GA 30303, 404-577-1234, FAX: 404-
588-4137.
    Contact Person: Joanne Kla, Center for Veterinary Medicine (HFV-
12), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 
20857, 240-276-9129, e-mail: NARMSinternationalMeeting@fda.hhs.gov, 
FAX: 240-276-9115.
    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone and 
fax number, and e-mail address), and written material and requests to 
make oral presentations, to the contact person (see Contact Person) on 
or before July 7, 2010. There is no registration fee for the public 
meeting. Early registration is recommended because seating is limited. 
Registration on the day of the public meeting will be provided on a 
space available basis beginning at 8 a.m. on the day of the meeting.
    If you need special accommodations due to a disability, please 
contact the Hyatt Regency-Atlanta hotel, (see Location) at least 7 days 
in advance.
    Interested persons may present data, information, or views, orally 
or in writing, on the topic of the discussion of the meeting. Written 
submissions may be made to the contact person on or before July 1, 
2010, for distribution at the meeting. Oral presentations from the 
public during the open public comment period will be scheduled between 
approximately 4 p.m. and 5 p.m. on July 16, 2010. Those desiring to 
make oral presentations should notify the contact person by July 1, 
2010, and submit a brief statement of the general nature of information 
they wish to present and an indication of the approximate time 
requested to make their presentation. Time allotted for each 
presentation may be limited. The contact person will inform each 
speaker of their schedule prior to the meeting.
    Comments: Regardless of attendance at the public meeting, 
interested persons may submit written comments to the Division of 
Dockets Management (HFA-305), Food and Drug Administration, 5630 
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments 
to http://www.regulations.gov. Submit a single copy of electronic 
comments or two paper copies of any mailed comments, except that 
individuals may submit one paper copy. Comments are to be identified 
with the docket number found in brackets in the heading of this 
document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday. The docket 
will remain open for written or electronic comments for 30 days 
following the meeting.
    Agenda: The meeting will address goals and challenges of monitoring 
antimicrobial susceptibility in foodborne bacteria, and present 
research on the microbiology and epidemiology of resistance. The agenda 
for the public meeting will be made available on the agency's Web site 
at http://www.fda.gov/AnimalVeterinary/SafetyHealth/
AntimicrobialResistance/
NationalAntimicrobialResistanceMonitoringSystem/ucm059135.htm.
    Transcripts: FDA will prepare a meeting transcript and make it 
available on the agency's Web site (see Agenda) after the meeting. FDA 
anticipates that transcripts will be available approximately 30 
business days after the meeting. The transcript will be available for 
public examination at the Division of Dockets Management (HFA-305), 
5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 
p.m., Monday through Friday. A transcript will also be available in 
either hardcopy or on CD-ROM, after submission of a Freedom of 
Information request. Written requests are to be sent to Division of 
Freedom of Information (HFI-35), Office of Management Programs, Food 
and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 
20857.

    Dated: March 30, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-7496 Filed 4-1-10; 8:45 am]
BILLING CODE 4160-01-S